[Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
D001120:Arginine / Q000627:therapeutic use; D002794:Choline / Q000627:therapeutic use; D002908:Chronic Disease; D005234:Fatty Liver / Q000188:drug therapy; D006505:Hepatitis / Q000188:drug therapy; D006710:Homocysteine / Q000627:therapeutic use; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D008293:Malates / Q000627:therapeutic use; D008715:Methionine / Q000627:therapeutic use; D009963:Orotic Acid / Q000627:therapeutic use; D008063:Thioctic Acid / Q000627:therapeutic use
D008293:Malates; D006710:Homocysteine; D009963:Orotic Acid; D008063:Thioctic Acid; D001120:Arginine; D008715:Methionine; D002794:Choline
Beobachtungen bei der Behandlung chronisch-entzündlicher Lebererkrankungen mit dem Präparat Hepasteril B comp.